| Year |
Citation |
Score |
| 2024 |
Galldiks N, Kaufmann TJ, Vollmuth P, Lohmann P, Smits M, Veronesi MC, Langen KJ, Rudá R, Albert NL, Hattingen E, Law I, Hutterer M, Soffietti R, Vogelbaum MA, Wen PY, et al. Challenges, Limitations and Pitfalls of PET and Advanced MRI in Patients with Brain Tumors - A Report of the PET/RANO Group. Neuro-Oncology. PMID 38466087 DOI: 10.1093/neuonc/noae049 |
0.607 |
|
| 2024 |
Kaiser L, Quach S, Zounek AJ, Wiestler B, Zatcepin A, Holzgreve A, Bollenbacher A, Bartos LM, Ruf VC, Böning G, Thon N, Herms J, Riemenschneider MJ, Stöcklein S, Brendel M, ... ... Albert NL, et al. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [F]FET PET, and TSPO PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38396261 DOI: 10.1007/s00259-024-06654-5 |
0.366 |
|
| 2024 |
Biechele G, Rauchmann BS, Janowitz D, Buerger K, Franzmeier N, Weidinger E, Guersel S, Schuster S, Finze A, Harris S, Lindner S, Albert NL, Wetzel C, Rupprecht R, Rominger A, et al. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease. Journal of Neuroinflammation. 21: 30. PMID 38263017 DOI: 10.1186/s12974-024-03020-y |
0.619 |
|
| 2024 |
Gold L, Barci E, Brendel M, Orth M, Cheng J, Kirchleitner SV, Bartos LM, Pötter D, Kirchner MA, Unterrainer LM, Kaiser L, Ziegler S, Weidner L, Riemenschneider MJ, Unterrainer M, ... ... Albert NL, et al. The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma. Biomedicines. 12. PMID 38255293 DOI: 10.3390/biomedicines12010188 |
0.816 |
|
| 2024 |
Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, et al. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. The Lancet. Oncology. 25: e29-e41. PMID 38181810 DOI: 10.1016/S1470-2045(23)00525-9 |
0.614 |
|
| 2024 |
Albert NL, Preusser M. Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas. Neuro-Oncology. PMID 38165287 DOI: 10.1093/neuonc/noad228 |
0.328 |
|
| 2023 |
Palleis C, Franzmeier N, Weidinger E, Bernhardt AM, Katzdobler S, Wall S, Ferschmann C, Harris S, Schmitt J, Schuster S, Gnörich J, Finze A, Biechele G, Lindner S, Albert NL, et al. Association of Neurofilament Light Chain, [F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS. Neurology. 102: e207901. PMID 38165362 DOI: 10.1212/WNL.0000000000207901 |
0.69 |
|
| 2023 |
Fraioli F, Albert N, Boellaard R, Galazzo IB, Brendel M, Buvat I, Castellaro M, Cecchin D, Fernandez PA, Guedj E, Hammers A, Kaplar Z, Morbelli S, Papp L, Shi K, et al. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38097746 DOI: 10.1007/s00259-023-06553-1 |
0.496 |
|
| 2023 |
Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M, von Baumgarten L, Albert NL, Huang RY, Mehta MP, et al. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. The Lancet. Oncology. 24: e438-e450. PMID 37922934 DOI: 10.1016/S1470-2045(23)00453-9 |
0.491 |
|
| 2023 |
Müller KJ, Biczok A, Schichor C, von Baumgarten L, Albert NL. The value of [F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37897618 DOI: 10.1007/s00259-023-06479-8 |
0.416 |
|
| 2023 |
Bartos LM, Kirchleitner SV, Kolabas ZI, Quach S, Beck A, Lorenz J, Blobner J, Mueller SA, Ulukaya S, Hoeher L, Horvath I, Wind-Mark K, Holzgreve A, Ruf VC, Gold L, ... ... Albert NL, et al. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Science Advances. 9: eadi8986. PMID 37889970 DOI: 10.1126/sciadv.adi8986 |
0.669 |
|
| 2023 |
Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D. EANM position paper: theranostics in brain tumours-the present and the future. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37698647 DOI: 10.1007/s00259-023-06425-8 |
0.452 |
|
| 2023 |
Weidner L, Lorenz J, Quach S, Braun FK, Rothhammer-Hampl T, Ammer LM, Vollmann-Zwerenz A, Bartos LM, Dekorsy FJ, Holzgreve A, Kirchleitner SV, Thon N, Greve T, Ruf V, Herms J, ... ... Albert NL, et al. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages. Acta Neuropathologica Communications. 11: 147. PMID 37697350 DOI: 10.1186/s40478-023-01651-5 |
0.733 |
|
| 2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, ... ... Albert NL, et al. Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37642707 DOI: 10.1007/s00259-023-06409-8 |
0.762 |
|
| 2023 |
Teske N, Biczok A, Quach S, Dekorsy FJ, Forbrig R, Bodensohn R, Niyazi M, Tonn JC, Albert NL, Schichor C, Ueberschaer M. Postoperative [Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37642702 DOI: 10.1007/s00259-023-06400-3 |
0.603 |
|
| 2023 |
Kolabas ZI, Kuemmerle LB, Perneczky R, Förstera B, Ulukaya S, Ali M, Kapoor S, Bartos LM, Büttner M, Caliskan OS, Rong Z, Mai H, Höher L, Jeridi D, Molbay M, ... ... Albert NL, et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell. PMID 37562402 DOI: 10.1016/j.cell.2023.07.009 |
0.504 |
|
| 2023 |
Albert NL, Nelwan DV, Fleischmann DF, Quach S, von Rohr K, Kaiser L, Teske N, Unterrainer LM, Bartos LM, Ruf VC, Brendel M, Riemenschneider MJ, Wetzel C, Herms J, Rupprecht R, et al. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37536737 DOI: 10.2967/jnumed.122.265247 |
0.764 |
|
| 2023 |
Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S, Weidinger E, Guersel S, Schuster S, Harris S, Schmitt J, Beyer L, Gnörich J, Lindner S, Albert NL, et al. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry. PMID 37495886 DOI: 10.1038/s41380-023-02188-8 |
0.565 |
|
| 2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, ... ... Albert NL, et al. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37358620 DOI: 10.1007/s00259-023-06315-z |
0.778 |
|
| 2023 |
Blobner J, Dengler L, Blobner S, Eberle C, Weller J, Teske N, Karschnia P, Rühlmann K, Heinrich K, Ziemann F, Greif PA, Jeremias I, Wuerstlein R, Hasselmann K, Dorostkar M, ... ... Albert NL, et al. Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma. Neuro-Oncology Advances. 5: vdad060. PMID 37287694 DOI: 10.1093/noajnl/vdad060 |
0.49 |
|
| 2023 |
Galldiks N, Albert NL, Wollring M, Werner JM, Lohmann P, Villanueva-Meyer JE, Fink GR, Langen KJ, Tonn JC. Advances in PET imaging for meningioma patients. Neuro-Oncology Advances. 5: i84-i93. PMID 37287577 DOI: 10.1093/noajnl/vdac113 |
0.615 |
|
| 2023 |
Menevse AN, Ammer LM, Vollmann-Zwerenz A, Kupczyk M, Lorenz J, Weidner L, Hussein A, Sax J, Mühlbauer J, Heuschneider N, Rohrmus C, Mai LS, Jachnik B, Stamova S, Volpin V, ... ... Albert NL, et al. TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma. Acta Neuropathologica Communications. 11: 75. PMID 37158962 DOI: 10.1186/s40478-023-01550-9 |
0.537 |
|
| 2023 |
Nikulin P, Zschaeck S, Maus J, Cegla P, Lombardo E, Furth C, Kaźmierska J, Rogasch JMM, Holzgreve A, Albert NL, Ferentinos K, Strouthos I, Hajiyianni M, Marschner SN, Belka C, et al. A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [Formula: see text]F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37079128 DOI: 10.1007/s00259-023-06197-1 |
0.377 |
|
| 2023 |
Wischmann J, Bartos LM, Brendel M, Albert NL, Forbrig R, Straube A, Masouris I. Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report. Journal of Neurology. PMID 37012466 DOI: 10.1007/s00415-023-11691-5 |
0.5 |
|
| 2023 |
Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, Bernhardt A, Fietzek U, Rauchmann BS, Stoecklein S, Quach S, ... ... Albert NL, et al. [F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. Journal of Neuroinflammation. 20: 68. PMID 36906584 DOI: 10.1186/s12974-023-02749-2 |
0.689 |
|
| 2023 |
Fleischmann DF, Büttner M, Unterrainer M, Corradini S, Zollner B, Hofmaier J, Bodensohn R, Thon N, Belka C, Bartenstein P, Albert NL, Niyazi M. High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With F-GE-180. Advances in Radiation Oncology. 8: 101185. PMID 36896209 DOI: 10.1016/j.adro.2023.101185 |
0.59 |
|
| 2023 |
Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H. FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36869178 DOI: 10.1007/s00259-023-06177-5 |
0.605 |
|
| 2023 |
Gnörich J, Reifschneider A, Wind K, Zatcepin A, Kunte ST, Beumers P, Bartos LM, Wiedemann T, Grosch M, Xiang X, Fard MK, Ruch F, Werner G, Koehler M, Slemann L, ... ... Albert NL, et al. Depletion and activation of microglia impact metabolic connectivity of the mouse brain. Journal of Neuroinflammation. 20: 47. PMID 36829182 DOI: 10.1186/s12974-023-02735-8 |
0.608 |
|
| 2023 |
Zounek AJ, Albert NL, Holzgreve A, Unterrainer M, Brosch-Lenz J, Lindner S, Bollenbacher A, Boening G, Rupprecht R, Brendel M, von Baumgarten L, Tonn JC, Bartenstein P, Ziegler S, Kaiser L. Feasibility of radiomic feature harmonization for pooling of [F]FET or [F]GE-180 PET images of gliomas. Zeitschrift Fur Medizinische Physik. PMID 36710156 DOI: 10.1016/j.zemedi.2022.12.005 |
0.746 |
|
| 2023 |
Zatcepin A, Kopczak A, Holzgreve A, Hein S, Schindler A, Duering M, Kaiser L, Lindner S, Schidlowski M, Bartenstein P, Albert N, Brendel M, Ziegler SI. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients. Zeitschrift Fur Medizinische Physik. PMID 36682921 DOI: 10.1016/j.zemedi.2022.11.008 |
0.617 |
|
| 2023 |
Palleis C, Forbrig R, Lehner L, Quach S, Albert NL, Brendel M, Schöberl F, Straube A. Lyme neuroborreliosis: An unusual case with extensive (peri)vasculitis of the middle cerebral artery. European Journal of Neurology. 30: 785-787. PMID 36636924 DOI: 10.1111/ene.15633 |
0.581 |
|
| 2022 |
Katzendobler S, Do A, Weller J, Rejeski K, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Tonn JC, von Baumgarten L, Quach S, Thon N. The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine. Frontiers in Oncology. 12: 1014711. PMID 36605448 DOI: 10.3389/fonc.2022.1014711 |
0.516 |
|
| 2022 |
Wiltgen T, Fleischmann DF, Kaiser L, Holzgreve A, Corradini S, Landry G, Ingrisch M, Popp I, Grosu AL, Unterrainer M, Bartenstein P, Parodi K, Belka C, Albert N, Niyazi M, et al. F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy. Radiation Oncology (London, England). 17: 198. PMID 36461120 DOI: 10.1186/s13014-022-02164-6 |
0.555 |
|
| 2022 |
Teske N, Albert NL, Forbrig R, Teske NC, von Baumgarten L, Kunz WG, Tonn JC, Thon N, Karschnia P. Advanced imaging findings in stroke-like migraine attacks after radiation therapy (SMART) syndrome. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36418589 DOI: 10.1007/s00259-022-06042-x |
0.446 |
|
| 2022 |
Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, ... ... Albert NL, et al. TSPO PET signal using [F]GE180 is associated with survival in recurrent gliomas. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36329288 DOI: 10.1007/s00259-022-06006-1 |
0.761 |
|
| 2022 |
Bartos LM, Kirchleitner SV, Blobner J, Wind K, Kunze LH, Holzgreve A, Gold L, Zatcepin A, Kolabas ZI, Ulukaya S, Weidner L, Quach S, Messerer D, Bartenstein P, Tonn JC, ... ... Albert NL, et al. 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model. Frontiers in Medicine. 9: 992993. PMID 36325388 DOI: 10.3389/fmed.2022.992993 |
0.677 |
|
| 2022 |
von Rohr K, Unterrainer M, Holzgreve A, Kirchner MA, Li Z, Unterrainer LM, Suchorska B, Brendel M, Tonn JC, Bartenstein P, Ziegler S, Albert NL, Kaiser L. Can Radiomics Provide Additional Information in [F]FET-Negative Gliomas? Cancers. 14. PMID 36230783 DOI: 10.3390/cancers14194860 |
0.751 |
|
| 2022 |
Li Z, Holzgreve A, Unterrainer LM, Ruf VC, Quach S, Bartos LM, Suchorska B, Niyazi M, Wenter V, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL, Kaiser L. Combination of pre-treatment dynamic [F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36227357 DOI: 10.1007/s00259-022-05988-2 |
0.681 |
|
| 2022 |
Becker-Bense S, Kaiser L, Becker R, Feil K, Muth C, Albert NL, Unterrainer M, Bartenstein P, Strupp M, Dieterich M. Acetyl-DL-leucine in cerebellar ataxia ([F]-FDG-PET study): how does a cerebellar disorder influence cortical sensorimotor networks? Journal of Neurology. PMID 35876876 DOI: 10.1007/s00415-022-11252-2 |
0.566 |
|
| 2022 |
Verger A, Barthel H, Tolboom N, Fraioli F, Cecchin D, Albert NL, van Berckel B, Boellaard R, Brendel M, Ekmekcioglu O, Semah F, Traub-Weidinger T, van de Weehaeghe D, Morbelli S, Guedj E. 2-[F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35840817 DOI: 10.1007/s00259-022-05913-7 |
0.676 |
|
| 2022 |
Zschaeck S, Weingärtner J, Lombardo E, Marschner S, Hajiyianni M, Beck M, Zips D, Li Y, Lin Q, Amthauer H, Troost EGC, van den Hoff J, Budach V, Kotzerke J, Ferentinos K, ... ... Albert NL, et al. 18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization. Frontiers in Oncology. 12: 870319. PMID 35756665 DOI: 10.3389/fonc.2022.870319 |
0.408 |
|
| 2022 |
Wang Y, Lombardo E, Avanzo M, Zschaek S, Weingärtner J, Holzgreve A, Albert NL, Marschner S, Fanetti G, Franchin G, Stancanello J, Walter F, Corradini S, Niyazi M, Lang J, et al. Deep learning based time-to-event analysis with PET, CT and joint PET/CT for head and neck cancer prognosis. Computer Methods and Programs in Biomedicine. 222: 106948. PMID 35752119 DOI: 10.1016/j.cmpb.2022.106948 |
0.343 |
|
| 2022 |
Galldiks N, Langen KJ, Albert NL, Law I, Kim MM, Villanueva-Meyer JE, Soffietti R, Wen PY, Weller M, Tonn JC. Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group. Neuro-Oncology. PMID 35674736 DOI: 10.1093/neuonc/noac131 |
0.453 |
|
| 2022 |
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, Brendel M, Albert NL, Wenter V, Schmidt-Hegemann NS, Kunz WG, et al. Total Tumor Volume on F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with Ac-PSMA-I&T. Biomedicines. 10. PMID 35625683 DOI: 10.3390/biomedicines10050946 |
0.638 |
|
| 2022 |
Quach S, Holzgreve A, von Baumgarten L, Niyazi M, Unterrainer M, Thon N, Stöcklein S, Bartenstein P, Tonn JC, Albert NL. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma-indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging. PMID 35610517 DOI: 10.1007/s00259-022-05844-3 |
0.454 |
|
| 2022 |
Bartos LM, Kunte ST, Beumers P, Xiang X, Wind K, Ziegler S, Bartenstein P, Choi H, Lee DS, Haass C, von Baumgarten L, Tahirovic S, Albert NL, Lindner S, Brendel M. Single cell radiotracer allocation via immunomagentic sorting (scRadiotracing) to disentangle PET signals at cellular resolution. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35589403 DOI: 10.2967/jnumed.122.264171 |
0.706 |
|
| 2022 |
Piccardo A, Albert NL, Borgwardt L, Fahey FH, Hargrave D, Galldiks N, Jehanno N, Kurch L, Law I, Lim R, Lopci E, Marner L, Morana G, Young Poussaint T, Seghers VJ, et al. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35536420 DOI: 10.1007/s00259-022-05817-6 |
0.469 |
|
| 2022 |
Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, ... ... Albert NL, et al. Longitudinal [F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model. Biomedicines. 10. PMID 35453488 DOI: 10.3390/biomedicines10040738 |
0.696 |
|
| 2022 |
Katzendobler S, Do A, Weller J, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Thon N, Tonn JC, Quach S. Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas. Frontiers in Neurology. 13: 822362. PMID 35432168 DOI: 10.3389/fneur.2022.822362 |
0.465 |
|
| 2022 |
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, et al. Feasibility of [Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35325283 DOI: 10.1007/s00259-022-05761-5 |
0.652 |
|
| 2022 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, et al. Correction to: EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. 49: 2100-2101. PMID 35254483 DOI: 10.1007/s00259-022-05755-3 |
0.665 |
|
| 2022 |
Holzgreve A, Völter F, Delker A, Kunz WG, Fabritius MP, Brendel M, Albert NL, Bartenstein P, Unterrainer M, Unterrainer LM. Detection of Splenic Tissue Using Tc-Labelled Denatured Red Blood Cells Scintigraphy-A Quantitative Single Center Analysis. Diagnostics (Basel, Switzerland). 12. PMID 35204576 DOI: 10.3390/diagnostics12020486 |
0.545 |
|
| 2022 |
Schuster S, Beyer L, Palleis C, Harris S, Schmitt J, Weidinger E, Prix C, Bötzel K, Danek A, Rauchmann BS, Stöcklein S, Lindner S, Unterrainer M, Albert NL, Mittlmeier LM, et al. Impact of Partial Volume Correction on [F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome. Brain Sciences. 12. PMID 35203967 DOI: 10.3390/brainsci12020204 |
0.679 |
|
| 2022 |
Unterrainer M, Mahler C, Schumacher AM, Ruf V, Blum B, Quach S, Brendel M, Rupprecht R, Bartenstein P, Kerschensteiner M, Kümpfel T, Albert NL. Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy. Clinical Nuclear Medicine. PMID 35195584 DOI: 10.1097/RLU.0000000000004093 |
0.71 |
|
| 2021 |
Kaiser L, Holzgreve A, Quach S, Ingrisch M, Unterrainer M, Dekorsy FJ, Lindner S, Ruf V, Brosch-Lenz J, Delker A, Böning G, Suchorska B, Niyazi M, Wetzel CH, Riemenschneider MJ, ... ... Albert NL, et al. Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas. Cancers. 14. PMID 35008218 DOI: 10.3390/cancers14010053 |
0.727 |
|
| 2021 |
Vettermann FJ, Diekmann C, Weidner L, Unterrainer M, Suchorska B, Ruf V, Dorostkar M, Wenter V, Herms J, Tonn JC, Bartenstein P, Riemenschneider MJ, Albert NL. L-type amino acid transporter (LAT) 1 expression in F-FET-negative gliomas. Ejnmmi Research. 11: 124. PMID 34905134 DOI: 10.1186/s13550-021-00865-9 |
0.547 |
|
| 2021 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, et al. EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34882261 DOI: 10.1007/s00259-021-05603-w |
0.673 |
|
| 2021 |
Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM, Barci E, Kälin RE, Glass R, Lindner S, Kaiser L, ... ... Albert NL, et al. PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook. Frontiers in Oncology. 11: 774017. PMID 34869017 DOI: 10.3389/fonc.2021.774017 |
0.783 |
|
| 2021 |
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, et al. Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34708249 DOI: 10.1007/s00259-021-05596-6 |
0.626 |
|
| 2021 |
Hadi I, Biczok A, Terpolilli N, Thorsteinsdottir J, Forbrig R, Albert NL, Yanchovski P, Zollner B, Bodensohn R, Corradini S, Bartenstein P, Belka C, Tonn JC, Schichor C, Niyazi M. Multimodal therapy of cavernous sinus meningioma: Impact of surgery and Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome. Neuro-Oncology Advances. 3: vdab114. PMID 34704034 DOI: 10.1093/noajnl/vdab114 |
0.387 |
|
| 2021 |
Marschner SN, Lombardo E, Minibek L, Holzgreve A, Kaiser L, Albert NL, Kurz C, Riboldi M, Späth R, Baumeister P, Niyazi M, Belka C, Corradini S, Landry G, Walter F. Risk Stratification Using F-FDG PET/CT and Artificial Neural Networks in Head and Neck Cancer Patients Undergoing Radiotherapy. Diagnostics (Basel, Switzerland). 11. PMID 34573924 DOI: 10.3390/diagnostics11091581 |
0.353 |
|
| 2021 |
Li Z, Kaiser L, Holzgreve A, Ruf VC, Suchorska B, Wenter V, Quach S, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [F]FET PET radiomics. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34490493 DOI: 10.1007/s00259-021-05526-6 |
0.542 |
|
| 2021 |
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S, et al. The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34272989 DOI: 10.1007/s00259-021-05485-y |
0.43 |
|
| 2021 |
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, et al. Value of PET imaging for radiation therapy. Nuklearmedizin. Nuclear Medicine. PMID 34261141 DOI: 10.1055/a-1525-7029 |
0.314 |
|
| 2021 |
Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, Bütof R, Combs SE, Derlin T, Eiber M, Fendler WP, Furth C, Gani C, Gkika E, et al. Value of PET imaging for radiation therapy. Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]. PMID 34259912 DOI: 10.1007/s00066-021-01812-2 |
0.314 |
|
| 2021 |
Mittlmeier LM, Suchorska B, Ruf V, Holzgreve A, Brendel M, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors. Cancers. 13. PMID 34202726 DOI: 10.3390/cancers13133163 |
0.759 |
|
| 2021 |
Fabritius MP, Geyer T, Ahmaddy F, Albert NL, Bartenstein P, Tiling R, Rübenthaler J, Holzgreve A. Breast Cancer Metastasis Mimicking Meningioma in 68Ga-DOTATOC PET/CT. Clinical Nuclear Medicine. PMID 34132678 DOI: 10.1097/RLU.0000000000003770 |
0.463 |
|
| 2021 |
Mittlmeier LM, Brendel M, Beyer L, Albert NL, Todica A, Zacherl MJ, Wenter V, Herlemann A, Kretschmer A, Ledderose ST, Schmidt-Hegemann NS, Kunz WG, Ricke J, Bartenstein P, Ilhan H, et al. Feasibility of Different Tumor Delineation Approaches for F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients. Frontiers in Oncology. 11: 663631. PMID 34094956 DOI: 10.3389/fonc.2021.663631 |
0.724 |
|
| 2021 |
Vettermann FJ, Harris S, Schmitt J, Unterrainer M, Lindner S, Rauchmann BS, Palleis C, Weidinger E, Beyer L, Eckenweber F, Schuster S, Biechele G, Ferschmann C, Milenkovic VM, Wetzel CH, ... ... Albert NL, et al. Impact of TSPO Receptor Polymorphism on [F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders. Life (Basel, Switzerland). 11. PMID 34073557 DOI: 10.3390/life11060484 |
0.725 |
|
| 2021 |
Unterrainer M, Ruf V, von Rohr K, Suchorska B, Mittlmeier LM, Beyer L, Brendel M, Wenter V, Kunz WG, Bartenstein P, Herms J, Niyazi M, Tonn JC, Albert NL. TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic F-FET PET? Frontiers in Oncology. 11: 645316. PMID 33996563 DOI: 10.3389/fonc.2021.645316 |
0.693 |
|
| 2021 |
Holzgreve A, Albert NL, Galldiks N, Suchorska B. Use of PET Imaging in Neuro-Oncological Surgery. Cancers. 13. PMID 33926002 DOI: 10.3390/cancers13092093 |
0.456 |
|
| 2021 |
Holzgreve A, Biczok A, Ruf VC, Liesche-Starnecker F, Steiger K, Kirchner MA, Unterrainer M, Mittlmeier L, Herms J, Schlegel J, Bartenstein P, Tonn JC, Albert NL, Suchorska B. PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging. Frontiers in Oncology. 11: 646387. PMID 33859946 DOI: 10.3389/fonc.2021.646387 |
0.443 |
|
| 2021 |
Unterrainer M, Lindner S, Beyer L, Gildehaus FJ, Todica A, Mittlmeier LM, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tonn JC, Albert NL, Bartenstein P, Ilhan H. PET Imaging of Meningioma Using the Novel SSTR-Targeting Peptide 18F-SiTATE. Clinical Nuclear Medicine. PMID 33782306 DOI: 10.1097/RLU.0000000000003607 |
0.569 |
|
| 2021 |
Mahler C, Schumacher AM, Unterrainer M, Kaiser L, Höllbacher T, Lindner S, Havla J, Ertl-Wagner B, Patzig M, Seelos K, Neitzel J, Mäurer M, Krumbholz M, Metz I, Brück W, ... ... Albert NL, et al. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy. Brain : a Journal of Neurology. PMID 33757118 DOI: 10.1093/brain/awab127 |
0.482 |
|
| 2021 |
Kreuzer A, Sauerbeck J, Scheifele M, Stockbauer A, Schönecker S, Prix C, Wlasich E, Loosli SV, M Kazmierczak P, Unterrainer M, Catak C, Janowitz D, Pogarell O, Palleis C, Perneczky R, ... Albert NL, et al. Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 611595. PMID 33603657 DOI: 10.3389/fnagi.2021.611595 |
0.637 |
|
| 2021 |
Wenter V, Albert NL, Ahmaddy F, Unterrainer M, Hornung J, Ilhan H, Bartenstein P, Spitzweg C, Kneidinger N, Todica A. The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study. Bmc Cancer. 21: 139. PMID 33550991 DOI: 10.1186/s12885-020-07745-w |
0.326 |
|
| 2021 |
Hadi I, Biczok A, Terpolilli N, Thorsteinsdottir J, Forbrig R, Albert N, Yanchovski P, Zollner B, Bodensohn R, Corradini S, Bartenstein P, Belka C, Tonn J, Schichor C, Niyazi M. OC-0078 Impact of surgery and PET-guided radiotherapy in therapy management of cavernous sinus meningioma Radiotherapy and Oncology. 161: S50-S51. DOI: 10.1016/s0167-8140(21)06772-4 |
0.435 |
|
| 2021 |
Biechele G, Rauchmann B, Janowitz D, Buerger K, Franzmeier N, Weidinger E, Guersel S, Schuster S, Finze A, Harris S, Schmitt J, Beyer L, Lindner S, Unterrainer M, Eckenweber F, ... Albert NL, et al. Associations between sex, body mass index, and the individual microglial response in Alzheimer’s disease Alzheimer's & Dementia. 17. DOI: 10.1002/alz.052772 |
0.528 |
|
| 2020 |
Mittlmeier LM, Unterrainer M, Rodler S, Todica A, Albert NL, Burgard C, Cyran CC, Kunz WG, Ricke J, Bartenstein P, Stief CG, Ilhan H, Staehler M. F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33369689 DOI: 10.1007/s00259-020-05165-3 |
0.507 |
|
| 2020 |
Palleis C, Sauerbeck J, Beyer L, Harris S, Schmitt J, Morenas-Rodriguez E, Finze A, Nitschmann A, Ruch-Rubinstein F, Eckenweber F, Biechele G, Blume T, Shi Y, Weidinger E, Prix C, ... ... Albert NL, et al. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33245166 DOI: 10.1002/mds.28395 |
0.541 |
|
| 2020 |
Holzgreve A, Pfluger T, Schmid I, Guntinas-Lichius O, Kunz WG, Ricke J, Bartenstein P, Albert NL, Unterrainer M. F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland. Diagnostics (Basel, Switzerland). 10. PMID 33172066 DOI: 10.3390/diagnostics10110908 |
0.59 |
|
| 2020 |
Vettermann FJ, Unterrainer M, Ruf V, Fleischmann DF, Rupprecht R, Forbrig R, Herms J, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET. Clinical Nuclear Medicine. PMID 33065624 DOI: 10.1097/RLU.0000000000003331 |
0.728 |
|
| 2020 |
Ueberschaer M, Vettermann FJ, Forbrig R, Unterrainer M, Siller S, Biczok AM, Thorsteinsdottir J, Cyran CC, Bartenstein P, Tonn JC, Albert NL, Schichor C. Simpson Grade Revisited - Intraoperative Estimation of the Extent of Resection in Meningiomas Versus Postoperative Somatostatin Receptor Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging. Neurosurgery. 88: 140-146. PMID 32827256 DOI: 10.1093/neuros/nyaa333 |
0.477 |
|
| 2020 |
Zaragori T, Castello A, Guedj E, Girard A, Galldiks N, Albert NL, Lopci E, Verger A. Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience. Clinical Nuclear Medicine. PMID 32804767 DOI: 10.1097/RLU.0000000000003240 |
0.421 |
|
| 2020 |
Völk S, Unterrainer M, Albert NL, Havla J, Gerdes LA, Schumacher M, Brendel M, Kaiser L, Adorjan K, Rupprecht R, Bartenstein P, Kümpfel T, Danek A. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. Clinical Nuclear Medicine. 45: e447-e448. PMID 32796248 DOI: 10.1097/RLU.0000000000003220 |
0.646 |
|
| 2020 |
Wenter V, Albert NL, Unterrainer M, Ahmaddy F, Ilhan H, Jellinek A, Knösel T, Bartenstein P, Spitzweg C, Lehner S, Todica A. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32683470 DOI: 10.1007/s00259-020-04952-2 |
0.311 |
|
| 2020 |
Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G, von Ungern-Sternberg B, Unterrainer M, Albert NL, Zwergal A, Levin J, et al. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of Neuroinflammation. 17: 208. PMID 32660586 DOI: 10.1186/S12974-020-01883-5 |
0.581 |
|
| 2020 |
Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, Bartenstein P. In response to: Anatomy of F-GE180, a failed radioligand for the TSPO protein. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32524162 DOI: 10.1007/s00259-020-04885-w |
0.636 |
|
| 2020 |
Unterrainer M, Eze C, Ilhan H, Marschner S, Roengvoraphoj O, Schmidt-Hegemann NS, Walter F, Kunz WG, Rosenschöld PMA, Jeraj R, Albert NL, Grosu AL, Niyazi M, Bartenstein P, Belka C. Recent advances of PET imaging in clinical radiation oncology. Radiation Oncology (London, England). 15: 88. PMID 32317029 DOI: 10.1186/s13014-020-01519-1 |
0.535 |
|
| 2020 |
Stoecklein VM, Stoecklein S, Galiè F, Ren J, Schmutzer M, Unterrainer M, Albert NL, Kreth FW, Thon N, Liebig T, Ertl-Wagner B, Tonn JC, Liu H. Resting-state fMRI Detects Alterations in Whole Brain Connectivity Related to Tumor Biology in Glioma Patients. Neuro-Oncology. PMID 32107555 DOI: 10.1093/neuonc/noaa044 |
0.47 |
|
| 2020 |
Fleischmann DF, Unterrainer M, Schön R, Corradini S, Maihöfer C, Bartenstein P, Belka C, Albert NL, Niyazi M. Margin reduction in radiotherapy for glioblastoma through F-fluoroethyltyrosine PET? - A recurrence pattern analysis. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 145: 49-55. PMID 31923709 DOI: 10.1016/j.radonc.2019.12.005 |
0.586 |
|
| 2019 |
Galldiks N, Lohmann P, Albert NL, Tonn JC, Langen KJ. Current status of PET imaging in neuro-oncology. Neuro-Oncology Advances. 1: vdz010. PMID 32642650 DOI: 10.1093/noajnl/vdz010 |
0.37 |
|
| 2019 |
Unterrainer M, Ruf V, Cyran CC, Brendel M, Thon N, Herms J, Schüller U, Tonn JC, Bartenstein P, Albert NL. Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT. Clinical Nuclear Medicine. 44: 923-924. PMID 31584491 DOI: 10.1097/Rlu.0000000000002790 |
0.78 |
|
| 2019 |
Galldiks N, Verger A, Zaragori T, Unterrainer M, Suchorska B, Lohmann P, Tonn JC, Langen KJ, Albert NL. Comment on "Hypometabolic gliomas on FET-PET-is there an inverted U-curve for survival?" Neuro-Oncology. 21: 1612-1613. PMID 31504819 DOI: 10.1093/neuonc/noz173 |
0.357 |
|
| 2019 |
Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic VM, Rupprecht R, Tonn JC, Belka C, ... ... Albert NL, et al. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-GE-180 PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31486876 DOI: 10.1007/S00259-019-04491-5 |
0.721 |
|
| 2019 |
Vettermann F, Suchorska B, Unterrainer M, Nelwan D, Forbrig R, Ruf V, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic F-FET PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31410540 DOI: 10.1007/S00259-019-04477-3 |
0.55 |
|
| 2019 |
Beyer L, Schnabel J, Kazmierczak P, Ewers M, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O, Perneczky R, Albert NL, Bartenstein P, Danek A, Buerger K, et al. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease. Neuroimage. Clinical. 24: 101949. PMID 31398553 DOI: 10.1016/j.nicl.2019.101949 |
0.608 |
|
| 2019 |
Fleischmann DF, Unterrainer M, Corradini S, Rottler M, Förster S, la Fougère C, Siepmann T, Schwaiger M, Bartenstein P, Belka C, Albert NL, Niyazi M. Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation. Plos One. 14: e0216111. PMID 31339892 DOI: 10.1371/journal.pone.0216111 |
0.557 |
|
| 2019 |
Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Brzak I, Neumann U, Saito T, et al. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second Generation Amyloid-beta Mouse Model. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31302633 DOI: 10.2967/Jnumed.119.227322 |
0.643 |
|
| 2019 |
Unterrainer M, Ruf V, Ilhan H, Vettermann F, Holzgreve A, Cyran CC, Tonn JC, Bartenstein P, Albert NL. Teaching NeuroImages: Advanced imaging of neurosarcoidosis with Ga-DOTATATE PET/CT. Neurology. 92: e2512-e2513. PMID 31110154 DOI: 10.1212/WNL.0000000000007544 |
0.66 |
|
| 2019 |
Galldiks N, Unterrainer M, Judov N, Stoffels G, Rapp M, Lohmann P, Vettermann F, Dunkl V, Suchorska B, Tonn JC, Kreth FW, Fink GR, Bartenstein P, Langen KJ, Albert NL. Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET - Clinical relevance in glioma patients. Neuro-Oncology. PMID 31077276 DOI: 10.1093/neuonc/noz083 |
0.534 |
|
| 2019 |
Unterrainer M, Ruf V, Ilhan H, Vettermann FJ, Cyran CC, Niyazi M, Bartenstein P, Tonn JC, Albert NL. 68Ga-DOTATOC PET/CT Differentiates Meningioma From Dural Metastases. Clinical Nuclear Medicine. 44: 412-413. PMID 30829858 DOI: 10.1097/RLU.0000000000002513 |
0.615 |
|
| 2019 |
Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. In response to: The validity of F-GE180 as a TSPO imaging agent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30826897 DOI: 10.1007/S00259-019-04294-8 |
0.642 |
|
| 2019 |
Galldiks N, Langen KJ, Albert NL, Chamberlain M, Soffietti R, Kim MM, Law I, Le Rhun E, Chang S, Schwarting J, Combs SE, Preusser M, Forsyth P, Pope W, Weller M, et al. PET Imaging in Patients with Brain Metastasis - Report of the RANO/PET Group. Neuro-Oncology. PMID 30615138 DOI: 10.1093/Neuonc/Noz003 |
0.386 |
|
| 2019 |
Unterrainer M, Ilhan H, Vettermann F, Cyran CC, Tonn JC, Niyazi M, Bartenstein P, Albert NL. Whole-Body Staging of Metastatic Atypical Meningioma Using 68Ga-DOTATATE PET/CT. Clinical Nuclear Medicine. 44: 227-228. PMID 30589668 DOI: 10.1097/RLU.0000000000002422 |
0.597 |
|
| 2019 |
Kunz M, Albert NL, Unterrainer M, la Fougere C, Egensperger R, Schüller U, Lutz J, Kreth S, Tonn JC, Kreth FW, Thon N. Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas. Neuro-Oncology. 21: 274-284. PMID 29893965 DOI: 10.1093/neuonc/noy098 |
0.424 |
|
| 2019 |
Unterrainer M, Niyazi M, Tonn JC, Ilhan H, Bartenstein P, Albert NL. A look ahead: future directions of SSR-directed imaging and therapy in meningioma Clinical and Translational Imaging. 7: 357-362. DOI: 10.1007/s40336-019-00333-4 |
0.345 |
|
| 2019 |
Unterrainer M, Niyazi M, Tonn JC, Ilhan H, Bartenstein P, Albert NL. Current status of SSR-directed imaging and therapy in meningioma Clinical and Translational Imaging. 7: 171-180. DOI: 10.1007/s40336-019-00331-6 |
0.351 |
|
| 2018 |
Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, et al. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [F]FDG: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30519867 DOI: 10.1007/s00259-018-4207-9 |
0.427 |
|
| 2018 |
Mahler C, Unterrainer M, Muth C, Egensperger R, Vomacka L, Lindner S, Ertl-Wagner B, Patzig M, Bartenstein P, Albert N, Kerschensteiner M, Kümpfel T. Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET. Neurology. 91: 936-937. PMID 30420457 DOI: 10.1212/Wnl.0000000000006516 |
0.528 |
|
| 2018 |
Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Ozmen L, Baumann K, Bartenstein P, Rominger A, Herms J, Brendel M. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Journal of Neuroinflammation. 15: 307. PMID 30400912 DOI: 10.1186/S12974-018-1347-6 |
0.588 |
|
| 2018 |
Vettermann FJ, Felsberg J, Reifenberger G, Hasselblatt M, Forbrig R, Berding G, la Fougère C, Galldiks N, Schittenhelm J, Weis J, Albert NL, Schüller U. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET. Clinical Nuclear Medicine. 43: 895-898. PMID 30358620 DOI: 10.1097/Rlu.0000000000002300 |
0.3 |
|
| 2018 |
Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, ... ... Albert NL, et al. Comparison of F-GE-180 and dynamic F-FET PET in high grade glioma: a double-tracer pilot study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30244386 DOI: 10.1007/S00259-018-4166-1 |
0.733 |
|
| 2018 |
Suchorska B, Albert NL, Tonn JC. Role of amino-tracer PET for decision-making in neuro-oncology. Current Opinion in Neurology. 31: 720-726. PMID 30239359 DOI: 10.1097/WCO.0000000000000616 |
0.377 |
|
| 2018 |
Vomacka L, Unterrainer M, Holzgreve A, Mille E, Gosewisch A, Brosch J, Ziegler S, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, Albert NL, Böning G. Voxel-wise analysis of dynamic F-FET PET: a novel approach for non-invasive glioma characterisation. Ejnmmi Research. 8: 91. PMID 30203138 DOI: 10.1186/s13550-018-0444-y |
0.571 |
|
| 2018 |
Unterrainer M, Diekmann C, Dorostkar M, Vettermann FJ, Kümpfel T, Tonn JC, Bartenstein P, Albert NL. Neurosarcoidosis Mimics High-Grade Glioma in Dynamic 18F-FET PET Due to LAT Expression. Clinical Nuclear Medicine. 43: 840-841. PMID 30179915 DOI: 10.1097/RLU.0000000000002266 |
0.574 |
|
| 2018 |
Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, Nübling G, Unterrainer M, Albert NL, Pogarell O, Perneczky R, Catak C, Bürger K, Bartenstein P, Bötzel K, et al. Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging? Frontiers in Neurology. 9: 483. PMID 29973914 DOI: 10.3389/fneur.2018.00483 |
0.718 |
|
| 2018 |
Schöberl F, Levin J, Remi J, Goldschagg N, Eren O, Okamura N, Unterrainer M, Rominger A, Albert N, Brendel M. IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation. Neurology. PMID 29970401 DOI: 10.1212/WNL.0000000000005859 |
0.417 |
|
| 2018 |
Suchorska B, Unterrainer M, Biczok A, Sosnova M, Forbrig R, Bartenstein P, Tonn JC, Albert NL, Kreth FW. F-FET-PET as a biomarker for therapy response in non-contrast enhancing glioma following chemotherapy. Journal of Neuro-Oncology. 139: 721-730. PMID 29948765 DOI: 10.1007/s11060-018-2919-0 |
0.557 |
|
| 2018 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, et al. Data on specificity of [F]GE180 uptake for TSPO expression in rodent brain and myocardium. Data in Brief. 19: 331-336. PMID 29892655 DOI: 10.1016/J.Dib.2018.04.133 |
0.663 |
|
| 2018 |
Unterrainer M, Fleischmann DF, Lindner S, Brendel M, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180. Clinical Nuclear Medicine. 43: 518-519. PMID 29742608 DOI: 10.1097/RLU.0000000000002113 |
0.78 |
|
| 2018 |
Röhrich M, Huang K, Schrimpf D, Albert NL, Hielscher T, von Deimling A, Schüller U, Dimitrakopoulou-Strauss A, Haberkorn U. Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29732524 DOI: 10.1007/s00259-018-4009-0 |
0.445 |
|
| 2018 |
Suchorska B, Albert NL, Bauer EK, Tonn JC, Galldiks N. The role of amino acid PET in the light of the new WHO classification 2016 for brain tumors. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 29696947 DOI: 10.23736/S1824-4785.18.03090-X |
0.356 |
|
| 2018 |
Hartenbach M, Weber S, Pilz M, Hartenbach S, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR, Albert NL. Combined [18F]-Fluoroethylcholine PET/CT and 99mTc-Macroaggregated Albumin SPECT/CT Predict Survival in Patients With Intermediate-Stage Hepatocellular Carcinoma. Clinical Nuclear Medicine. 43: 477-481. PMID 29659390 DOI: 10.1097/RLU.0000000000002092 |
0.535 |
|
| 2018 |
Fiedler L, Kellner M, Gosewisch A, Oos R, Böning G, Lindner S, Albert N, Bartenstein P, Reulen HJ, Zeidler R, Gildehaus FJ. Evaluation of Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. Nuclear Medicine and Biology. 60: 55-62. PMID 29571067 DOI: 10.1016/j.nucmedbio.2018.02.004 |
0.343 |
|
| 2018 |
Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Correction to: Biological tumour volumes of gliomas in early and standard 20-40 minF-FET PET images differ according to IDH mutation status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29541813 DOI: 10.1007/s00259-018-3991-6 |
0.44 |
|
| 2018 |
Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL. TSPO PET with [F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 45: 1423-1431. PMID 29523925 DOI: 10.1007/S00259-018-3974-7 |
0.696 |
|
| 2018 |
Unterrrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL. Biological tumour volumes of gliomas in early and standard 20-40 minF-FET PET images differ according to IDH mutation status. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29487977 DOI: 10.1007/S00259-018-3969-4 |
0.568 |
|
| 2018 |
Unterrainer M, Maihoefer C, Cyran CC, Bartenstein P, Niyazi M, Albert NL. 68Ga-DOTATATE PET/CT Reveals Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma in a Case of Suspected Sphenoid Wing Meningioma. Clinical Nuclear Medicine. PMID 29401153 DOI: 10.1097/RLU.0000000000001985 |
0.528 |
|
| 2018 |
Wenter V, Sommer NN, Kooijman H, Maurus S, Treitl M, Czihal M, Dechant C, Unterrainer M, Albert NL, Treitl KM. Clinical value of [18F]FDG-PET/CT and 3D-black-blood 3T-MRI for the diagnosis of large vessel vasculitis and single-organ vasculitis of the aorta. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of.... PMID 29307167 DOI: 10.23736/S1824-4785.18.03036-4 |
0.423 |
|
| 2018 |
Suchorska B, Schüller U, Biczok A, Kreth FW, Lenski M, Albert NL, Giese A, Ertl-Wagner B, Ingrisch M, Tonn J. Contrast enhancement as a prognostic factor in IDH1/2 mutant glioma. Journal of Clinical Oncology. 36: 2029-2029. DOI: 10.1200/JCO.2018.36.15_SUPPL.2029 |
0.437 |
|
| 2018 |
Ueberschaer M, Vettermann F, Forbrig R, Bartenstein P, Albert NL, Tonn J, Schichor C. MNGI-35. SIMPSON GRADING REVISITED: SURGEONS ESTIMATION OF MENINGIOMA REMOVAL VS. POSTOPERATIVE 68GA-DOTATATE PET/CT Neuro-Oncology. 20: vi156-vi156. DOI: 10.1093/NEUONC/NOY148.651 |
0.473 |
|
| 2018 |
Niyazi M, Fleischmann D, Unterrainer M, Bartenstein P, Albert N, Belka C. PO-0723: TSPO-PET for RT treatment planning using [18F]GE-180 – first in human results in GBM p atients Radiotherapy and Oncology. 127: S369-S370. DOI: 10.1016/s0167-8140(18)31033-8 |
0.531 |
|
| 2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert NL, Becker-Bense S, Brandt T, Ziegler S, la Fougère C, Dieterich M, Bartenstein P. In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study. Frontiers in Neurology. 8: 665. PMID 29312111 DOI: 10.3389/fneur.2017.00665 |
0.669 |
|
| 2017 |
Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, Ermoschkin L, Gosewisch A, Brunegraf A, Buckley C, Kümpfel T, Rupprecht R, Ziegler S, Kerschensteiner M, Bartenstein P, et al. TSPO imaging using the novel PET ligand [(18)F]GE-180: quantification approaches in patients with multiple sclerosis. Ejnmmi Research. 7: 89. PMID 29150726 DOI: 10.1186/S13550-017-0340-X |
0.72 |
|
| 2017 |
Unterrainer M, Niyazi M, Ruf V, Bartenstein P, Albert NL. The endothelial prostate-specific membrane antigen is highly expressed in gliosarcoma and visualized by [68Ga]-PSMA-11 PET: a theranostic outlook for brain tumor patients? Neuro-Oncology. 19: 1698-1699. PMID 29045711 DOI: 10.1093/neuonc/nox172 |
0.432 |
|
| 2017 |
Suchorska B, Giese A, Biczok A, Unterrainer M, Weller M, Drexler M, Bartenstein P, Schüller U, Tonn JC, Albert NL. Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-Oncology. PMID 29016996 DOI: 10.1093/neuonc/nox153 |
0.535 |
|
| 2017 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [(18)F]GE180 PET quantification. Neuroimage. PMID 28988133 DOI: 10.1016/J.Neuroimage.2017.10.006 |
0.675 |
|
| 2017 |
Albert NL, Unterrainer M, Fleischmann DF, Lindner S, Vettermann F, Brunegraf A, Vomacka L, Brendel M, Wenter V, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M. TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28821920 DOI: 10.1007/s00259-017-3799-9 |
0.718 |
|
| 2017 |
Filss CP, Albert NL, Böning G, Kops ER, Suchorska B, Stoffels G, Galldiks N, Shah NJ, Mottaghy FM, Bartenstein P, Tonn JC, Langen KJ. O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres. Ejnmmi Research. 7: 64. PMID 28815478 DOI: 10.1186/s13550-017-0316-x |
0.586 |
|
| 2017 |
Unterrainer M, Ilhan H, Todica A, Bartenstein P, Albert NL. Epidural Metastases From Follicular Thyroid Cancer Mimicking Meningiomas in 68Ga-DOTATATE PET. Clinical Nuclear Medicine. 42: 805-806. PMID 28806249 DOI: 10.1097/RLU.0000000000001793 |
0.46 |
|
| 2017 |
Brendel M, Focke C, Blume T, Peters F, Deussing M, Probst F, Jaworska A, Overhoff F, Albert N, Lindner S, von Ungern-Sternberg B, Bartenstein P, Haass C, Kleinberger G, Herms J, et al. Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life-Span of Wild-Type Mice: A PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705919 DOI: 10.2967/Jnumed.117.195107 |
0.649 |
|
| 2017 |
Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Le Rhun E, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC. PET Imaging in Patients with Meningioma - Report of the RANO/PET Group. Neuro-Oncology. PMID 28605532 DOI: 10.1093/neuonc/nox112 |
0.413 |
|
| 2017 |
Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zähringer M, Suchorska B, Wenter V, Illigens BM, Bartenstein P, Albert NL. Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment? Ejnmmi Research. 7: 48. PMID 28560582 DOI: 10.1186/s13550-017-0295-y |
0.715 |
|
| 2017 |
Wenter V, Herlemann A, Fendler WP, Ilhan H, Tirichter N, Bartenstein P, Stief CG, la Fougère C, Albert NL, Rominger A, Gratzke C. Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy. Oncotarget. 8: 44131-44140. PMID 28484088 DOI: 10.18632/oncotarget.17311 |
0.339 |
|
| 2017 |
Russmann V, Brendel M, Mille E, Helm-Vicidomini A, Beck R, Günther L, Lindner S, Rominger A, Keck M, Salvamoser JD, Albert NL, Bartenstein P, Potschka H. Identification of brain regions predicting epileptogenesis by serial [(18)F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy. Neuroimage. Clinical. 15: 35-44. PMID 28462087 DOI: 10.1016/j.nicl.2017.04.003 |
0.675 |
|
| 2017 |
Kunz WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, Bollenbacher A, Tonn JC, Schichor C, Rominger A, Albert NL, Bartenstein P, Reiser MF, Cyran CC. Improved Detection of Transosseous Meningiomas Using Ga-DOTATATE PET/CT Compared with Contrast-Enhanced MRI. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 58: 1580-1587. PMID 28450556 DOI: 10.2967/jnumed.117.191932 |
0.542 |
|
| 2017 |
Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, Albert NL, Carlsen J, Lindner S, Gildehaus FJ, Ozmen L, Suárez-Calvet M, Bartenstein P, Baumann K, Ewers M, et al. Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis. Frontiers in Aging Neuroscience. 9: 8. PMID 28197095 DOI: 10.3389/Fnagi.2017.00008 |
0.614 |
|
| 2017 |
Fleischmann DF, Unterrainer M, Bartenstein P, Belka C, Albert NL, Niyazi M. F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images? Journal of Neuro-Oncology. 132: 277-286. PMID 28102485 DOI: 10.1007/s11060-016-2366-8 |
0.606 |
|
| 2017 |
Cicone F, Galldiks N, Minniti G, Filss CP, Scopinaro F, Prior JO, Albert NL, Langen KJ. Comment on Hatzoglou et al: Dynamic contrast-enhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury. Neuro-Oncology. 19: 300-301. PMID 28040712 DOI: 10.1093/neuonc/now283 |
0.316 |
|
| 2017 |
Vettermann FJ, Neumann JE, Suchorska B, Bartenstein P, Giese A, Dorostkar MM, Albert NL, Schüller U. K27M midline gliomas display malignant progression by imaging and histology. Neuropathology and Applied Neurobiology. 43: 458-462. PMID 27997032 DOI: 10.1111/nan.12371 |
0.405 |
|
| 2017 |
Unterrainer M, Galldiks N, Suchorska B, Kowalew LC, Wenter V, Schmid-Tannwald C, Niyazi M, Bartenstein P, Langen KJ, Albert NL. F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 58: 584-589. PMID 27754904 DOI: 10.2967/jnumed.116.180075 |
0.591 |
|
| 2017 |
Wenter V, Albert NL, Brendel M, Fendler WP, Cyran CC, Bartenstein P, Friederichs J, Müller JP, Militz M, Hacker M, Hungerer S. [(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation. European Journal of Nuclear Medicine and Molecular Imaging. 44: 432-440. PMID 27704194 DOI: 10.1007/s00259-016-3528-9 |
0.606 |
|
| 2017 |
Suchorska B, Unterrainer M, Biczok A, Albert N, Tonn J, Kreth F. NIMG-100. USEFULNESS OF 18FET-PET FOR CHEMOTHERAPY MONITORING IN NON-CONTRAST ENHANCING GLIOMA Neuro-Oncology. 19: vi165-vi165. DOI: 10.1093/NEUONC/NOX168.669 |
0.606 |
|
| 2017 |
Suchorska B, Sosnova M, Unterrainer M, Biczok A, Bartenstein P, Albert N, Tonn J. NIMG-39. PATTERNS OF INTERSECTIONAL TUMOUR VOLUME IN T2-WEIGHTED MRI AND 18F-FET PET CORRELATE WITH OUTCOME IN GLIOBLASTOMA Neuro-Oncology. 19: vi150-vi150. DOI: 10.1093/NEUONC/NOX168.614 |
0.667 |
|
| 2017 |
Fleischmann D, Unterrainer M, Corradini S, Rottler M, Bartenstein P, Belka C, Albert N, Niyazi M. EP-1124: PET-MRI prior to re-irradiation of high-grade glioma patients - a planning study Radiotherapy and Oncology. 123: S613-S614. DOI: 10.1016/S0167-8140(17)31560-8 |
0.507 |
|
| 2017 |
Fleischmann D, Albert N, Unterrainer M, Bartenstein P, Belka C, Niyazi M. EP-1122: TSPO PET imaging RT treatment planning in malignant glioma Radiotherapy and Oncology. 123: S613. DOI: 10.1016/S0167-8140(17)31558-X |
0.513 |
|
| 2017 |
Fleischmann D, Unterrainer M, Schön R, Corradini S, Maihöfer C, Bartenstein P, Belka C, Albert N, Niyazi M. PO-0638: FET PET prior to primary RT of glioblastoma patients - a recurrence pattern analysis Radiotherapy and Oncology. 123: S334. DOI: 10.1016/S0167-8140(17)31075-7 |
0.504 |
|
| 2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert N, Becker-Bense S, Ziegler S, la Fougere C, Bartenstein P, Brandt T, Dieterich M. P 61 Glial activation accelerates behavioural compensation of acute unilateral vestibulopathy Clinical Neurophysiology. 128: e358. DOI: 10.1016/j.clinph.2017.06.137 |
0.52 |
|
| 2016 |
Romagna A, Unterrainer M, Schmid-Tannwald C, Brendel M, Tonn JC, Nachbichler SB, Muacevic A, Bartenstein P, Kreth FW, Albert NL. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties? Radiation Oncology (London, England). 11: 139. PMID 27769279 DOI: 10.1186/s13014-016-0713-8 |
0.698 |
|
| 2016 |
Deutschländer A, la Fougère C, Boetzel K, Albert NL, Gildehaus FJ, Bartenstein P, Xiong G, Cumming P. Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients. Neuroimage. Clinical. 12: 41-6. PMID 27408789 DOI: 10.1016/J.Nicl.2016.06.007 |
0.411 |
|
| 2016 |
Holzgreve A, Brendel M, Gu S, Carlsen J, Mille E, Böning G, Mastrella G, Unterrainer M, Gildehaus FJ, Rominger A, Bartenstein P, Kälin RE, Glass R, Albert NL. Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches. Frontiers in Neuroscience. 10: 260. PMID 27378835 DOI: 10.3389/fnins.2016.00260 |
0.801 |
|
| 2016 |
Langen KJ, Tonn JC, Albert NL, Galldiks N. Letter to the Editor: "Comparing the Volume of Brain Metastases in F-18-FET-PET and MRI". World Neurosurgery. 89: 722. PMID 27184392 DOI: 10.1016/j.wneu.2015.10.084 |
0.435 |
|
| 2016 |
Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology. PMID 27106405 DOI: 10.1093/Neuonc/Now058 |
0.678 |
|
| 2016 |
Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schüller U, Bartenstein P, Tonn JC, Albert NL. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 1177-82. PMID 27033893 DOI: 10.2967/jnumed.115.171033 |
0.573 |
|
| 2016 |
Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert N, Beck R, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Kleinberger G, Haass C, Herms J, Rominger A. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912428 DOI: 10.2967/Jnumed.115.167858 |
0.634 |
|
| 2016 |
Suchorska B, Albert NL, Tonn JC. Usefulness of PET Imaging to Guide Treatment Options in Gliomas. Current Treatment Options in Neurology. 18: 4. PMID 26815310 DOI: 10.1007/s11940-015-0384-z |
0.359 |
|
| 2016 |
Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu LÖ, Kluge A, Ziebell M, et al. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26780619 DOI: 10.1007/S00259-015-3304-2 |
0.361 |
|
| 2016 |
Suchorska B, Kraus T, Biczok A, Weller M, Unterrainer M, Schueller U, Schmid-Tannwald C, Bartenstein P, Giese A, Tonn J, Albert NL. Correlation of IDH mutation, 1p/19q co-deletion and 18FET-PET derived time-to-peak analysis as prognostic markers in glioma Journal of Clinical Oncology. 34: 2058-2058. DOI: 10.1200/JCO.2016.34.15_SUPPL.2058 |
0.602 |
|
| 2016 |
Suchorska B, Kraus T, Biczok A, Weller M, Unterrainer M, Schüller U, Schmid-Tannwald C, Bartenstein P, Giese A, Albert N, Tonn J. NIMG-34. 18FET-PET UPTAKE DYNAMICS SERVES AS AN ADDITIONAL IMAGING BIOMARKER IN ASTROCYTOMAS WITH IDH1/2 MUTATION AND NO LOH1p/19q Neuro-Oncology. 18: vi131-vi132. DOI: 10.1093/neuonc/now212.546 |
0.646 |
|
| 2016 |
Suchorska B, Biczok A, Lenski M, Albert NL, Schüller U, Tonn J. P07.16 Prognostic value of contrast enhancement and histopathological grading in diffuse gliomas depends on IDH1/2 mutation Neuro-Oncology. 18: iv37-iv37. DOI: 10.1093/NEUONC/NOW188.127 |
0.448 |
|
| 2016 |
Fleischmann D, Unterrainer M, Bartenstein P, Belka C, Albert N, Niyazi M. PO-0650: Prognostic value of minimal time to peak in dynamic 18F-FET-PET for high-grade glioma re-irradiation Radiotherapy and Oncology. 119: S304. DOI: 10.1016/S0167-8140(16)31900-4 |
0.552 |
|
| 2016 |
Becker-Bense S, Stephan T, Albert N, Brendel M, Unterrainer M, Xiong G, Mille E, Habs M, Herz M, Schwaiger M, Dieterich M, Bartenstein P. EP 30. Hybrid-H215O-PET-fMRI measures during galvanic vestibular stimulation Clinical Neurophysiology. 127: e247-e248. DOI: 10.1016/j.clinph.2016.05.085 |
0.633 |
|
| 2015 |
Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, Todica A, Brendel M, Tonn JC, Bartenstein P, la Fougère C. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26666239 DOI: 10.1007/s00259-015-3276-2 |
0.731 |
|
| 2015 |
Michl M, Lehner S, Paprottka PM, Ilhan H, Bartenstein P, Heinemann V, Boeck S, Albert NL, Fendler WP. PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26609176 DOI: 10.2967/jnumed.115.165613 |
0.438 |
|
| 2015 |
Wenter V, Müller JP, Albert NL, Lehner S, Fendler WP, Bartenstein P, Cyran CC, Friederichs J, Militz M, Hacker M, Hungerer S. The diagnostic value of [(18)F]FDG PET for the detection of chronic osteomyelitis and implant-associated infection. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26547722 DOI: 10.1007/s00259-015-3221-4 |
0.556 |
|
| 2015 |
Hartenbach M, Weber S, Albert NL, Hartenbach S, Hirtl A, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR. Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1661-6. PMID 26405170 DOI: 10.2967/jnumed.115.158758 |
0.538 |
|
| Show low-probability matches. |